Description
Overview:
Clinical Pharmaceutics and Technical Services within the NHS in Wales ensure specialist pharmaceutical products are prescribed, formulated, dispensed or manufactured for some of our most vulnerable patients in settings such as: Cancer services, ITU, HDU and Neonatal Intensive Care.
Each specialist unit offering these services must comply with the EU rules governing Good Manufacturing Practice (GMP) and the Quality Assurance of Aseptic Preparation Standards (QAAPS). The Medicines and Healthcare Products Regulatory Agency (MHRA) and our Regional Quality Assurance Specialist Pharmacist, audit to these rules and guidance to ensure compliance.
Learning and sharing experience from self-inspection, internal and external audit is a valuable exercise and the topics for this learning event will focus on recent regional audit findings and risk reduction priorities.
Designed for:
Accountable and Authorised Pharmacists, QA Practitioners and Senior Technicians
Speakers:
Regional Quality Assurance Lead
Learning Outcomes
At the end of the session those attending should be able to:
1. Overview of the planned new process for EL Audit in Wales.
2. Examine the new Quick Solutions software system which will be used to conduct the new EL Audit process.
3. Scrutinise each module to recognise the amount and type of information the system requires for audits or supplier assurance to be completed.
